FTC sues main pharmacy reward administrators over insulin costs The agency brought action towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list cost of existence-saving insulin drugs. Insurers will go on vertically integrating to maintain extra income in-residence, and federal scrutiny https://gunnerzdxtp.activoblog.com/31780073/5-simple-techniques-for-healthcare-news